Advertisement

Read Now: News and Research From ICAAC 2014
The Body PRO covers CROI 2009



  

HIV Treatment Strategies

Mari Kitahata, M.D., and Jonathan Sterne, M.D. Ever Upward: "When to Start" Debate Turns to CD4+ Cell Count of 500
Dueling studies -- one presented by Mari Kitahata, M.D., the other by Jonathan Sterne, M.D. -- offer strikingly different views on the benefits of HAART initiation at a CD4+ threshold of 500. However, both appear to solidify the wisdom of starting therapy before CD4+ cell count drops below 350.
Read or listen (22 min.):
More Top Stories:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

  
Advertisement